Ranolazine and Pulmonary Hypertension

Study Type: Interventional
Age/Gender Requirements: 18-80 years (male/female)
Sponsor: Northwestern University
Purpose: Individuals with angina, right ventricular ischemia, and pulmonary arterial hypertension are eligible to participate in this study which will “determine if the medication, ranolazine (study drug), can help improve blood flow to your heart, increase your exercise capacity and improve your quality of life.”
http://hcp.lv/cCYEKI